Cardiac amyloidosis: the pathologist’s point of view
Key result
Cardiac amyloidosis often requires tissue sampling to determine the specific protein type for targeted treatment.
Why the study?
Cardiac amyloidosis presentation is often elusive leading to diagnostic delay, requiring tissue sampling and pathological typing of deposited proteins to direct specific treatment.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Tissue sampling remains essential for subtyping; leaves open validation of non-invasive alternatives in cardiac amyloidosis.
Structured PICO
P
Population
Patients with cardiac amyloidosis
This review outlines the pathological features of cardiac amyloidosis, emphasizing the necessity of tissue sampling and protein typing to guide specific treatments.
Cite This Study
Gaspari et al. (2022) conducted a review in Cardiac amyloidosis. Cardiac amyloidosis is an infiltrative disease often requiring tissue sampling and pathological analysis to determine the specific protein type for targeted treatment.